Payment overview · 2025
General Payments
$19.93
1 reported records · 1 companies
Healthcare provider profile · identity verified
Daniel Schowengerdt, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · COLDWATER, KS · NPI 1194727230
Verified facts
What the public records show
CMS Open Payments records show Daniel Schowengerdt, M.D. received $19.93 in general payments during 2025 across 1 reported records.
Philips North America LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $19.93 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.93 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Vest Therapy Und Normalized: vest therapy und |
Device | Philips North America LLC | $19.93 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 539 | 51 |
| Lisinopril | Lisinopril | 365 | 43 |
| Potassium Chloride | Potassium Chloride | 348 | 35 |
| Atorvastatin Calcium | Atorvastatin Calcium | 284 | 33 |
| Furosemide | Furosemide | 252 | 31 |
| Simvastatin | Simvastatin | 244 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 214 | 14 |
| Sertraline Hcl | Sertraline Hcl | 214 | 18 |
| Gabapentin | Gabapentin | 210 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 209 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 197 | 24 |
| Divalproex Sodium Er | Divalproex Sodium | 196 | 12 |
| Lorazepam | Lorazepam | 187 | 21 |
| Tramadol Hcl | Tramadol Hcl | 173 | 27 |
| Famotidine | Famotidine | 171 | 15 |
| Amlodipine Besylate | Amlodipine Besylate | 161 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 150 | 16 |
| Bupropion Xl | Bupropion Hcl | 143 | 11 |
| Metformin Hcl | Metformin Hcl | 138 | 16 |
| Trazodone Hcl | Trazodone Hcl | 133 | 17 |
| Glipizide | Glipizide | 122 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 117 | 13 |
| Losartan Potassium | Losartan Potassium | 108 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 106 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 105 | 16 |
| Clozapine | Clozapine | 104 | suppressed |
| Bumetanide | Bumetanide | 92 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 91 | 11 |
| Olanzapine | Olanzapine | 89 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 83 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 83 | suppressed |
| Omeprazole | Omeprazole | 83 | 13 |
| Mirtazapine | Mirtazapine | 80 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 77 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 75 | suppressed |
| Meloxicam | Meloxicam | 75 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 72 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 68 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 67 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 65 | suppressed |
| Alprazolam | Alprazolam | 63 | 13 |
| Finasteride | Finasteride | 62 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 62 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 59 | 14 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 58 | suppressed |
| Ramipril | Ramipril | 58 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 57 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 56 | suppressed |
| Levetiracetam | Levetiracetam | 55 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 54 | suppressed |
| Clonazepam | Clonazepam | 53 | suppressed |
| Topiramate | Topiramate | 53 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 50 | suppressed |
| Fentanyl | Fentanyl | 49 | suppressed |
| Eliquis | Apixaban | 48 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 47 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 45 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 43 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 43 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 43 | suppressed |
| Baclofen | Baclofen | 42 | suppressed |
| Lamotrigine | Lamotrigine | 42 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 40 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 39 | suppressed |
| Prednisone | Prednisone | 39 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Memantine Hcl | Memantine Hcl | 38 | suppressed |
| Olanzapine Odt | Olanzapine | 38 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | suppressed |
| Celecoxib | Celecoxib | 36 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 36 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 35 | suppressed |
| Xarelto | Rivaroxaban | 35 | suppressed |
| Digoxin | Digoxin | 34 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 34 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 33 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 33 | suppressed |
| Paliperidone Er | Paliperidone | 32 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 32 | suppressed |
| Glipizide Er | Glipizide | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 31 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Risperidone | Risperidone | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Acitretin | Acitretin | 26 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 26 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 24 | suppressed |
| Allopurinol | Allopurinol | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Ozempic | Semaglutide | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Tresiba | Insulin Degludec | 22 | suppressed |
| Atenolol | Atenolol | 20 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 20 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 20 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 20 | suppressed |
| Cartia Xt | Diltiazem Hcl | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Acetazolamide | Acetazolamide | 17 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Spironolactone | Spironolactone | 17 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 16 | suppressed |
| Cefdinir | Cefdinir | 16 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 16 |
| Fluconazole | Fluconazole | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 13 |
| Nystop | Nystatin | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Cephalexin | Cephalexin | 14 | 11 |
| Entacapone | Entacapone | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Prevalite | Cholestyramine | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | 12 |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 13 | suppressed |
| Carvedilol | Carvedilol | 13 | suppressed |
| Jardiance | Empagliflozin | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | 11 |
| Lactulose | Lactulose | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 11 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.93 · 1 records | Philips North America LLC | Vest Therapy Und | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error